NICODERM CQ 21 mg/24h

Nicoderm CQ 21 mg/24h is a transdermal patch designed to help manage nicotine dependence. This extended-release patch delivers nicotine steadily over 24 hours, supporting smoking cessation efforts.

Nicoderm CQ 21 mg/24h is used as an aid to quit smoking. The patch provides a controlled release of nicotine, helping to reduce withdrawal symptoms and cravings. It is typically part of a comprehensive smoking cessation program that may include behavioral therapy and support.

Common effects of using Nicoderm CQ 21 mg/24h may include skin irritation at the application site, headaches, or insomnia. Some users may experience dizziness or nausea. These effects are generally mild and temporary.

Handle Nicoderm CQ 21 mg/24h patches carefully to avoid accidental exposure to children or pets. Apply the patch to clean, dry skin and avoid contact with water or excessive heat. Consult a healthcare provider before use if you have any medical conditions or are taking other medications.

Nicoderm CQ 21 mg/24h may interact with certain medications, including those metabolized by the liver's CYP450 enzymes. Avoid using other nicotine products simultaneously to prevent excessive nicotine intake. Alcohol consumption should be moderated as it may affect the patch's adherence and absorption.